Phase 2 Hormone Receptor Positive HER-2 Negative Breast Cancer trials recruiting now

All Hormone Receptor Positive HER-2 Negative Breast Cancer trials, every phase

Other phases for Hormone Receptor Positive HER-2 Negative Breast Cancer

Phase 2 Hormone Receptor Positive HER-2 Negative Breast Cancer trials

• A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
  NCT06369285 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 53 locations
• Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer
  NCT06201234 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 36 locations
• Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
  NCT05573126 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Female · 14 locations
• VS-6766+Abema+Fulv in Met HR+/HER- BC
  NCT05608252 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.